Rules for Out-of-Country Drug Treatments
Ontario Regulation 326/26 amends Regulation 552 of the Revised Regulations of Ontario, 1990, under the Health Insurance Act. The regulation changes the conditions under which Ontario’s public health insurance system may cover insured services received outside Canada, particularly services involving the administration of drugs.
The amendments establish specific eligibility requirements for out-of-country services that primarily involve administering a drug, including the provision of the drug itself. Under the new clause 28.4(2)(b.1), four conditions must be satisfied for such services to qualify for coverage. First, an identical or equivalent service must be performed in Ontario. Second, both the drug and its administration must be publicly funded in Ontario, either fully or partially, for a person in the same medical circumstances as the insured individual. Third, access to the drug in Ontario must be temporarily unavailable. Finally, the delay in obtaining the drug must make travel outside Canada necessary to avoid death or medically significant irreversible tissue damage.
These requirements establish a specific framework for drug-related services rather than relying exclusively on the existing conditions governing other out-of-country medical services. The amendments clarify this distinction by modifying clause 28.4(2)(c), which continues to apply to services not covered by the new drug-administration provision. Corresponding changes to subsection 28.4(7) and subsection 28.4(7.1) align the related provisions with the revised eligibility criteria.
A particularly significant change involves the revocation of paragraph 4 of subsection 28.4(7). The regulation introduces subsection 28.4(10), which establishes transitional rules governing services that previously could have qualified under that paragraph. Such services are not insured services, and no payment is available unless they satisfy the new requirements for drug-administration services.
The transitional provisions apply to services rendered on or after October 1, 2011. Their application is not limited to new claims. They also extend to cases in which an application for payment has already been submitted to the General Manager or an appeal concerning payment has been brought before the Appeal Board. Consequently, the amendments may affect the outcome of longstanding claims and appeals, potentially changing expectations about reimbursement for certain medical services obtained outside Canada.
Overall, Ontario Regulation 326/26 narrows and clarifies eligibility for public reimbursement of certain out-of-country medical services. By requiring temporary domestic unavailability, public funding eligibility and a serious medical necessity for travel, the regulation establishes more specific conditions for coverage of drug-administration services.
Ontario (326/2026) October 27, 2026
Disclaimer: Insights are for informational purposes only and does not reflect RRI’s official position or constitute legal opinion.
